Online Peer Support for Adults With Uncontrolled Asthma
Tests a digital peer support program promoted by GPs in adults with asthma.
Plain-language title generated from the registry record
Registry title: Εffectiveness of a Digital Social Intervention in Primary Care
Key facts
- Where
- Exeter, Leicester, London, Newcastle upon Tyne, and Norwich, United KingdomSee the 5 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 99 years old?
Source: NCT06849245, who can take part
Where in United Kingdom
- South West Peninsula Regional Research Delivery NetworkExeter, United KingdomNot yet recruiting
- East Midlands Regional Research Delivery NetworkLeicester, United KingdomTaking people
- North London Regional Research Delivery NetworkLondon, United KingdomTaking people
- North East and North CumbriaNewcastle upon Tyne, United KingdomTaking people
- East of England Regional Research Delivery NetworkNorwich, United KingdomTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Queen Mary University of London
- Trial code
- NCT06849245
- Record updated
- 19 November 2025
- Original description
The goal of this study is to deliver a definitive randomised controlled trial to measure the effectiveness and assess cost-effectiveness of a digital social intervention for patients with asthma, composed of promoting engagement with online peer support in a primary care consultation, followed by engagement with online peer support for 12 months. The main questions/objectives this study aims to answer/address are:Read full original descriptionShow less
Measuring Whether Promotion of a Digital Social Intervention by Primary Care Healthcare Professionals and Subsequent Engagement With Online Peer Support Improves Health and Well-being of Patients With Asthma and is Cost-effective: a Randomised Controlled Trial
The goal of this study is to deliver a definitive randomised controlled trial to measure the effectiveness and assess cost-effectiveness of a digital social intervention for patients with asthma, composed of promoting engagement with online peer support in a primary care consultation, followed by engagement with online peer support for 12 months. The main questions/objectives this study aims to answer/address are:
* Does promoting engagement with an online health community in primary care help people with troublesome asthma to experience fewer asthma symptoms? * To assess cost-effectiveness of the intervention (including quality of life, well-being, use of healthcare services etc); stakeholder satisfaction (patients and healthcare professionals) with the intervention; fidelity of protocol delivery; context in which positive outcomes can be triggered.
Inclusion: To participate in the study, participants will need to:; Be adult asthma patients (aged 18 to 99) who have expressed their interest in digital social interventions in the recruitment survey; Report troublesome asthma (i.e. an ACT score of less than 20) in the recruitment survey); Be competent to consent for themselves, as determined by the healthcare professional delivering the consultation; There are no specific criteria for selecting participants for the exit interviews (a convenience sample of patients and clinicians will be used and recruitment will continue until data saturation).
Exclusion: Patients receiving institutional long-term care (receiving total care in residential homes or living in nursing homes); Patients who are already members of the Asthma + Lung UK online health community or other asthma online health communities/Facebook groups (i.e. general use of social media will not prevent participation); Palliative or end of life patients; Patients considered unsuitable to take part in the study by their general practitioners/nurses; There are no specific criteria for selecting participants for the exit interviews (a convenience sample of patients and clinicians will be used and recruitment will continue until data saturation).